By Kathryn Calkins
Staff Writer

The FDA's Division of Drug Marketing, Advertising and Communications (DDMAC) has few obvious teeth when it comes to companies found promoting their products before they receive FDA approval: it does not levy penalties such as fines, or impose regulatorily mandated delays in product approvals or restrictions on marketing.